National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Patent Portfolio Statistics

National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government look like?

Total Applications: 35,070
Granted Patents: 21,775
Grant Index 67.4 %
Abandoned/Rejected Applications: 10,534 (32.6%)
In-Process Applications: 2,756
Average Grant Time: 3.39 Years
Average Office Actions: 2.07

Which Technology Area National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1644 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 1,204
1648 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 1,151
1634 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 1,144
1633 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 1,120
1632 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 1,068

How many patents are National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government filing every year?

Year Total Applications
2022 0*
2021 4*
2020 195
2019 243
2018 844

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government in USPTO?

Publication number:
Application number: 17/310,432

Abstract:
None

Publication date:
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Huijun Yin


Publication number: US20220008060A1
Application number: 17/385,230

Abstract:
Among other things, there is disclosed structure and methods for maintaining access to a location in the body while reducing or eliminating the potential for pulling an access device (e.g. a catheter) back through an opening. An introducer sheath includes a distal indented portion and a balloon, so that once placed in a desired location through tissue, the balloon can be inflated to anchor the sheath against retraction. In particular embodiments, structure and methods for accessing the pericardial cavity via the right atrial appendage are shown.

Publication date: 2022-01-13
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: E Fearnot Neal


Publication number: US20210299239A1
Application number: 17/344,627

Abstract:
The present invention provides the induction of novel Th1 response, the induction of cytotoxic T cells and anti-cancer/anti-allergic activity techniques. Provided is a combination of a CpG oligonucleotide and an STING agonist. Also provided is a composition which contains an STING agonist, can be used as a type-I adjuvant, and is characterized in that the STING agonist is administered together with a CpG oligonucleotide.
Further provided is an anti-cancer agent comprising a CpG oligonucleotide and is characterized in that the CpG oligonucleotide is administered together with an STING agonist. Still further provided is a composition which contains a CpG oligonucleotide and can be used for reducing or eliminating the IgE-inducing activity of an STING agonist.


Publication date: 2021-09-30
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Burcu Temizoz


How are National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/310,432 Aromatic Ring Or Heteroaromatic Ring Compounds, Preparation Method Therefor And Medical Use Thereof
17/385,230 Vascular Anchoring Introducer Sheath OPAP Central, Docket
17/344,627 Novel Th1-Inducing Adjuvant Comprising Combination Of Different Nucleic Acid Adjuvants, And Use Of Same Docketed New Case – Ready for Examination OPAP Central, Docket
17/333,256 Composition For Prophylaxis Or Treatment Of Il-8 Related Diseases Docketed New Case – Ready for Examination OPAP Central, Docket